Anterior distribution of stage T1c nonpalpable tumors in radical prostatectomy specimens

被引:73
|
作者
Takashima, R
Egawa, S
Kuwao, S
Baba, S
机构
[1] Kitasato Univ, Sch Med, Dept Urol, Kanagawa 2288555, Japan
[2] Kitasato Univ, Sch Med, Dept Pathol, Kanagawa 2288555, Japan
关键词
D O I
10.1016/S0090-4295(02)01525-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine the anatomic patterns of tumor distribution in radical prostatectomy specimens from nonpalpable prostate cancer. Methods. Tumor maps directly traced from histologic slides of 62 radical prostatectomy specimens were superimposed by a computer-assisted imaging technique to create an idealized prostate gland at three levels: apex, mid-prostate, and base. To investigate specific patterns of tumor distribution, the sites of tumor in each quadrant were compared according to risk group stratification. The tumor extent was compared with the patterns of positivity in routine sextant biopsies. Results. Among all patients, the tumor frequency was 85.5% in the mid-gland, 82.3% in the apex, and 48.4% in the base. Analysis by quadrant showed that tumors were significantly denser in the apex to mid-prostate. The primary extent of these tumors appeared to lie predominantly in the anterior half of the gland. Biopsy yields at the apex and mid-prostate appeared low compared with the frequency of cancers at these levels. No patterns specific to the different risk groups were found, but no tumors within the anterior base were found in the low-risk group. Conclusions. The primary extent of nonpalpable tumors appeared to lie predominantly in the anterior half of the gland at the apex to mid-prostate levels. Additional biopsy cores taken from more anterior regions of the gland may enhance the detection of nonpalpable cancers further. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:692 / 697
页数:6
相关论文
共 50 条
  • [21] THE DISTRIBUTION OF RESIDUAL CANCER IN RADICAL PROSTATECTOMY SPECIMENS IN STAGE-A PROSTATE-CANCER
    GREENE, DR
    EGAWA, S
    NEERHUT, G
    FLANAGAN, W
    WHEELER, TM
    SCARDINO, PT
    JOURNAL OF UROLOGY, 1991, 145 (02): : 324 - 329
  • [22] Prospective evaluation of men with stage T1c adenocarcinoma of the prostate
    Carter, HB
    Sauvageot, J
    Walsh, PC
    Epstein, JI
    JOURNAL OF UROLOGY, 1997, 157 (06): : 2206 - 2209
  • [23] Radiation therapy as treatment for stage T1c prostate cancers
    Gerald E. Hanks
    Alexandra L. Hanlon
    Wayne H. Pinover
    Tahseen I. Al-Saleem
    Timothy E. Schultheiss
    World Journal of Urology, 1997, 15 : 369 - 372
  • [24] Radiation therapy as treatment for stage T1c prostate cancers
    Hanks, GE
    Hanlon, AL
    Pinover, WH
    Al-Saleem, TI
    Schultheiss, TE
    WORLD JOURNAL OF UROLOGY, 1997, 15 (06) : 369 - 372
  • [25] Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: A preliminary study
    Olumi, AF
    Richie, JP
    Schultz, DJ
    D'Amico, AV
    UROLOGY, 2000, 56 (02) : 273 - 277
  • [26] Characteristics of insignificant clinical T1c prostate tumors - A contemporary analysis
    Bastian, PJ
    Mangold, LA
    Epstein, JI
    Partin, AW
    CANCER, 2004, 101 (09) : 2001 - 2005
  • [27] Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens
    Ishii, Junichiro
    Ohori, Makoto
    Scardino, Peter
    Tsuboi, Toshiki
    Slawin, Kevin
    Wheeler, Thomas
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (09) : 817 - 821
  • [28] Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: A prospective multicenter clinical trial
    Southwick, PC
    Catalona, WJ
    Partin, AW
    Slawin, KM
    Brawer, MK
    Flanigan, RC
    Patel, A
    Richie, JP
    Walsh, PC
    Scardino, PT
    Lange, PH
    Gasior, GH
    Parson, RE
    Loveland, KG
    JOURNAL OF UROLOGY, 1999, 162 (04): : 1346 - 1351
  • [29] Nonpalpable (stage T1c) prostate cancer: Prediction of "insignificant" disease using free/total (F/T) serum PSA levels and biopsy findings.
    Epstein, JI
    Chan, DW
    Sokoll, LJ
    Walsh, PC
    Cox, JL
    Carter, HB
    JOURNAL OF UROLOGY, 1998, 159 (05): : 293 - 293
  • [30] Assessment of relative tumor burden in patients with clinical T1c prostate cancer treated with either external beam or radical prostatectomy
    Hintz, BL
    Murphy, JS
    Kaswick, JA
    Bellman, GC
    Ruel, CJ
    Kagan, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (04): : 332 - 337